These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 8404380)

  • 21. Inflammatory bowel disease course in liver transplant versus non-liver transplant patients for primary sclerosing cholangitis: LIVIBD, an IG-IBD study.
    Ribaldone DG; Imperatore N; Le Grazie M; Furfaro F; Balestrieri P; De Blasio F; Fagoonee S; Mosso E; Boano V; Reggio D; Sarli E; Castiglione F; Milla M; Vecchi M; Saracco GM; Salizzoni M; Romagnoli R; Fiorino G; Astegiano M;
    Dig Liver Dis; 2021 Jun; 53(6):712-716. PubMed ID: 32972831
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Colorectal cancer in inflammatory bowel disease: what is the real magnitude of the risk?
    Dyson JK; Rutter MD
    World J Gastroenterol; 2012 Aug; 18(29):3839-48. PubMed ID: 22876036
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ulcerative colitis has an aggressive course after orthotopic liver transplantation for primary sclerosing cholangitis.
    Papatheodoridis GV; Hamilton M; Mistry PK; Davidson B; Rolles K; Burroughs AK
    Gut; 1998 Nov; 43(5):639-44. PubMed ID: 9824344
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Statin Exposure Is Not Associated with Reduced Prevalence of Colorectal Neoplasia in Patients with Inflammatory Bowel Disease.
    Shah SC; Glass J; Giustino G; Hove JRT; Castaneda D; Torres J; Kumar A; Elman J; Ullman TA; Itzkowitz SH
    Gut Liver; 2019 Jan; 13(1):54-61. PubMed ID: 30400722
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interactions between primary sclerosing cholangitis and inflammatory bowel disease: implications in the adult liver transplant setting.
    Liu K; Strasser SI; Koorey DJ; Leong RW; Solomon M; McCaughan GW
    Expert Rev Gastroenterol Hepatol; 2017 Oct; 11(10):949-960. PubMed ID: 28627935
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Asymptomatic De Novo Inflammatory Bowel Disease Late After Liver Transplantation for Primary Sclerosing Cholangitis: A Case Report.
    Åberg F; Abdulle A; Mäkelä A; Nissinen M
    Transplant Proc; 2015 Nov; 47(9):2775-7. PubMed ID: 26680092
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The impact of inflammatory bowel disease post-liver transplantation for primary sclerosing cholangitis.
    Joshi D; Bjarnason I; Belgaumkar A; O'Grady J; Suddle A; Heneghan MA; Aluvihare V; Rela M; Heaton N; Agarwal K
    Liver Int; 2013 Jan; 33(1):53-61. PubMed ID: 22103794
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inflammatory Bowel Disease and Primary Sclerosing Cholangitis: A Review of the Phenotype and Associated Specific Features.
    Palmela C; Peerani F; Castaneda D; Torres J; Itzkowitz SH
    Gut Liver; 2018 Jan; 12(1):17-29. PubMed ID: 28376583
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inflammatory bowel disease in patients with primary sclerosing cholangitis: clinical characterization in liver transplanted and nontransplanted patients.
    Jørgensen KK; Grzyb K; Lundin KE; Clausen OP; Aamodt G; Schrumpf E; Vatn MH; Boberg KM
    Inflamm Bowel Dis; 2012 Mar; 18(3):536-45. PubMed ID: 21456044
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis following orthotopic liver transplantation.
    Loftus EV; Aguilar HI; Sandborn WJ; Tremaine WJ; Krom RA; Zinsmeister AR; Graziadei IW; Wiesner RH
    Hepatology; 1998 Mar; 27(3):685-90. PubMed ID: 9500695
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk for colorectal neoplasia in patients with colonic Crohn's disease and concomitant primary sclerosing cholangitis.
    Braden B; Halliday J; Aryasingha S; Sharifi Y; Checchin D; Warren BF; Kitiyakara T; Travis SP; Chapman RW
    Clin Gastroenterol Hepatol; 2012 Mar; 10(3):303-8. PubMed ID: 22037429
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease.
    Brackmann S; Andersen SN; Aamodt G; Langmark F; Clausen OP; Aadland E; Fausa O; Rydning A; Vatn MH
    Scand J Gastroenterol; 2009; 44(1):46-55. PubMed ID: 18609187
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of colectomy in preventing recurrent primary sclerosing cholangitis in liver transplant recipients.
    Buchholz BM; Lykoudis PM; Ravikumar R; Pollok JM; Fusai GK
    World J Gastroenterol; 2018 Jul; 24(28):3171-3180. PubMed ID: 30065563
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunosuppression after liver transplantation for primary sclerosing cholangitis influences activity of inflammatory bowel disease.
    Jørgensen KK; Lindström L; Cvancarova M; Karlsen TH; Castedal M; Friman S; Schrumpf E; Foss A; Isoniemi H; Nordin A; Holte K; Rasmussen A; Bergquist A; Vatn MH; Boberg KM
    Clin Gastroenterol Hepatol; 2013 May; 11(5):517-23. PubMed ID: 23333218
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inflammatory bowel disease complicated by primary sclerosing cholangitis and cirrhosis: is restorative proctocolectomy safe?
    Lian L; Menon KV; Shen B; Remzi F; Kiran RP
    Dis Colon Rectum; 2012 Jan; 55(1):79-84. PubMed ID: 22156871
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Surgical management of ulcerative colitis in the presence of primary sclerosing cholangitis.
    Poritz LS; Koltun WA
    Dis Colon Rectum; 2003 Feb; 46(2):173-8. PubMed ID: 12576890
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of Inflammatory Bowel Disease Subtypes on the Post-liver Transplant Outcomes of Patients with Primary Sclerosing Cholangitis.
    Lee DU; Menegas S; Lee KJ; Pu A; Bhowmick K; Ponder R; Fan GH; Chou H; Lee K; Urrunaga NH
    Dig Dis Sci; 2023 Sep; 68(9):3781-3800. PubMed ID: 37450231
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Natural history of low grade dysplasia in patients with primary sclerosing cholangitis and ulcerative colitis.
    Venkatesh PG; Jegadeesan R; Gutierrez NG; Sanaka MR; Navaneethan U
    J Crohns Colitis; 2013 Dec; 7(12):968-73. PubMed ID: 23433613
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Colorectal cancer and cholangiocarcinoma in patients with primary sclerosing cholangitis and inflammatory bowel disease.
    Manninen P; Karvonen AL; Laukkarinen J; Aitola P; Huhtala H; Collin P
    Scand J Gastroenterol; 2015 Apr; 50(4):423-8. PubMed ID: 25636976
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inflammatory bowel disease in liver transplanted patients.
    Filipec Kanizaj T; Mijic M
    World J Gastroenterol; 2017 May; 23(18):3214-3227. PubMed ID: 28566881
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.